Faron Pharmaceuticals Oyj Owners

Health Care & Life Sciences » Pharmaceuticals | Faron Pharmaceuticals Oyj

Faron Pharmaceuticals Oyj | Ownership

Companies that own Faron Pharmaceuticals Oyj

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Aviva Investors Global Services Ltd.

1,518,814

4.88%

-61,984

02/28/2018

Hargreave Hale Ltd.

1,475,875

4.76%

-158,875

0.02%

06/14/2018

Polar Capital LLP

1,452,381

4.68%

-150,000

0.01%

05/14/2018

Rhenman & Partners Asset Management AB

759,265

2.45%

165,865

0.08%

12/31/2017

Keskinäinen Eläkevakuutusyhtiö Ilmarinen

636,721

2.04%

0.01%

12/31/2017

Legal & General Investment Management Ltd.

116,000

0.37%

-360,000

06/19/2018

Octopus Investments Ltd.

64,181

0.21%

64,181

05/31/2017

City Financial Investment Co. Ltd.

-1,267,530

05/08/2018

About Faron Pharmaceuticals Oyj

View Profile

Address	Joukahaisenkatu 6 Turku FP 20520 Finland
Employees	-
Website	http://www.faron.com
Updated	07/08/2019
Faron Pharmaceuticals Oy engages in the provision of biopharmaceutical development. The company focuses on novel treatments for medical conditions such as acute organ traumas, cancer immunotherapy and vascular damage. It operates through the Traumakine and Clevegen brands for acute respiratory distress syndrome, and for pre-clinical anti-Clever-1 antibody respectively.